Monument Therapeutics: Funding, Investors & Team (Sep 2026)
Monument Tx is an independent UK based biotechnology company formed as a spin-out from Cambridge Cognition in 2021. Monument Tx develops products to treat serious diseases of the central nervous system. Our precision medicine approach utilises proprietary digital biomarkers to reduce heterogeneity and identify patients with homogenous underlying neurobiology, which are then matched with appropriately targeted compounds. Using biomarkers to more accurately identify patients with a disease sub-type most likely to respond to a particular treatment is already successfully used in the treatment of cancer. Now Monument Tx brings digital biomarkers to neuroscience drug development to provide a precision medicine approach in clinical areas of high unmet need. Contact us to learn more about our company and solutions.
Monument Therapeutics has raised $1.3M across 1 funding round on record, the most recent an undisclosed round of $1.3M announced in Oct 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Monument Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Monument Therapeutics Funding Rounds
Monument Therapeutics Founders and Leadership Team
Contact details for the Monument Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Monument Therapeutics Funding Compared to Other Biotechnology Startups
Monument Therapeutics' latest round of $1.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Monument Therapeutics in Biotechnology and Cambridge
Companies Similar to Monument Therapeutics
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Monument Therapeutics Funding FAQs
What does Monument Therapeutics do?
Monument Tx is an independent UK based biotechnology company formed as a spin-out from Cambridge Cognition in 2021. Monument Tx develops products to treat serious diseases of the central nervous system. Our precision medicine approach utilises proprietary digital biomarkers to reduce heterogeneity and identify patients with homogenous underlying neurobiology, which are then matched with appropriately targeted compounds. Using biomarkers to more accurately identify patients with a disease sub-type most likely to respond to a particular treatment is already successfully used in the treatment of cancer. Now Monument Tx brings digital biomarkers to neuroscience drug development to provide a precision medicine approach in clinical areas of high unmet need. Contact us to learn more about our company and solutions.
How much funding has Monument Therapeutics raised?
Monument Therapeutics has raised $1.3M across 1 round on record. The most recent is an undisclosed round of $1.3M announced in Oct 2024.
When did Monument Therapeutics last raise funding?
Monument Therapeutics' most recent funding round on record is an undisclosed round of $1.3M, announced in Oct 2024.
Who founded Monument Therapeutics?
FundedIQ lists Jenny Barnett (Founder) at Monument Therapeutics.
Where is Monument Therapeutics headquartered?
Monument Therapeutics is based in Cambridge, Cambridgeshire, United Kingdom.
How many employees does Monument Therapeutics have?
Monument Therapeutics is in the 1-10 employee band.
How does Monument Therapeutics' funding compare to other Biotechnology startups?
Monument Therapeutics' latest round of $1.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Monument Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Monument Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.